References
- LiewSMDoustJGlasziouPCardiovascular risk scores do not account for the effect of treatment: a reviewHeart20119768969721474616
- PiephoRWBealJAn overview of hypertensive therapy in the 20th centuryJ Clin Pharmacol20004096797710975068
- EndoAThe discovery and development of HMG-CoA reductase inhibitorsJ Lipid Res199233156915821464741
- Pharmaceutical Management AgencyAnnual Review 2014WellingtonPharmaceutical Management Agency2014
- Ministry of Health (New Zealand)Cardiovascular Disease Risk Assessment, Updated 2013 (New Zealand Primary Care Handbook 2012)WellingtonMinistry of Health (New Zealand)2013
- Ministry of Health (New Zealand)National Health Index Data Dictionary (version 5.3)WellingtonMinistry of Health (New Zealand)2009
- Ministry of Health (New Zealand)Primary care data and statsWellingtonMinistry of Health (New Zealand)2015 [cited February 10, 2016]. Available from: http://www.health.govt.nz/nz-health-statistics/health-statistics-and-data-sets/primary-care-data-and-statsAccessed February 10, 2016
- PayneRAAbelGASimpsonCRA retrospective cohort study assessing patient characteristics and the incidence of cardiovascular disease using linked routine primary and secondary care dataBMJ Open201222e000723
- MerryAHHBoerJMASchoutenLJValidity of coronary heart diseases and heart failure based on hospital discharge and mortality data in the Netherlands using the cardiovascular registry Maastricht cohort studyEur J Epidemiol20092423724719337843
- PajunenPKoukkunenHKetonenMThe validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart diseaseEur J Cardiovasc Prev Rehabil200512213213715785298
- BeagleholeRStewartAWalkerPValidation of coronary heart disease hospital discharge dataAust N Z J Med19871743463476046
- WellsLRiddellTKerrACohort profile: the PREDICT cardiovascular disease cohort in New Zealand primary care (PREDICT-CVD 19)Int J Epidemiol20174612226686841
- SelakVGuYRafterNCrengleSKerrABullenCDispensing data captures individual-level use of aspirin for cardiovascular disease prevention, despite availability over-the-counterN Z Med J201612914352128
- Hippisley-CoxJCouplandCVinogradovaYPredicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2Br Med J200833676591475148218573856
- MainousAKoopmanRDiazVAA coronary heart disease risk score based on patient-reported informationAm J Cardiol2007991236124117478150
- GoffDLloyd-JonesDMBennettG2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesCirculation2014129S49S7324222018
- RidkerPBuringJRifaiNCookNRDevelopment and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds risk scoreJAMA200729761161917299196
- RidkerPPaynterNRifaiNGazianoJMCookNRC-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds risk score for menCirculation20081182243225118997194
- Heart Protection Study Collaborative GroupMRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trialLancet200236072212114036
- MehtaSWellsSGreyCInitiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16Eur J Prev Cardiol201421219220223033546
- VinogradovaYCouplandCBrindlePHippisley-CoxJDiscontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care databaseBMJ2016353i330527353261
- SimonsLALevisGSimonsJApparent discontinuation rates in patients prescribed lipid-lowering drugsMed J Aust199616442082118604188
- ChapmanRHBennerJSPetrillaAAPredictors of adherence with antihypertensive and lipid-lowering therapyArch Intern Med20051651147115215911728
- BennerJSGlynnRJMogunHNeumannPJWeinsteinMCAvornJLong-term persistence in statin therapy in the elderlyJAMA200228845546112132975
- AndradeSEKahlerKHFrechFChanKAMethods for evaluation of medication adherence and persistence using automated databasesPharmacoepidemiol Drug Saf20061556557416514590
- LiuKColangeloLADaviglusMLCan antihypertensive treatment restore the risk of cardiovascular disease to ideal levels? The Coronary Artery Development in Young Adults (CARDIA) study and the Multi-Ethnic Study of Atherosclerosis (MESA)J Am Heart Assoc201549e00227526391135